Estimates of the excess prevalence and economic burden associated with pregnancy-related and long-term morbidities of PCOS in 2020 in the United States
| Morbidity . | Excess prevalence of morbidity in PCOS (%) . | Annual costs in millions in 2020 USD (% of total costs in category) . |
|---|---|---|
| Pregnancy-related morbidities | ||
| GDM | 16.7 % | 61 (16) |
| gHTN | 14.3 % | 187 (50) |
| Preeclampsia | 8.1 % | 127 (34) |
| Total cost of pregnancy-related morbidities | 375 (100.0) | |
| Long-term morbidities | ||
| Type 2 diabetes mellitus | 3.93%* | 1500 (38) |
| MI | ___ | ___ |
| Stroke | 4.3%* | 2400 (62) |
| Total cost of long-term morbidities | 3900 (100.0) | |
| Total economic burden due to pregnancy-related or long-term morbidities | 4275 |
| Morbidity . | Excess prevalence of morbidity in PCOS (%) . | Annual costs in millions in 2020 USD (% of total costs in category) . |
|---|---|---|
| Pregnancy-related morbidities | ||
| GDM | 16.7 % | 61 (16) |
| gHTN | 14.3 % | 187 (50) |
| Preeclampsia | 8.1 % | 127 (34) |
| Total cost of pregnancy-related morbidities | 375 (100.0) | |
| Long-term morbidities | ||
| Type 2 diabetes mellitus | 3.93%* | 1500 (38) |
| MI | ___ | ___ |
| Stroke | 4.3%* | 2400 (62) |
| Total cost of long-term morbidities | 3900 (100.0) | |
| Total economic burden due to pregnancy-related or long-term morbidities | 4275 |
Abbreviations: GDM, gestational diabetes mellitus; gHTN, gestational hypertension; MI, myocardial infarction; PCOS, polycystic ovary syndrome; USD, US dollars.
*Weighted average prevalence of T2DM and stroke across age groups.
Estimates of the excess prevalence and economic burden associated with pregnancy-related and long-term morbidities of PCOS in 2020 in the United States
| Morbidity . | Excess prevalence of morbidity in PCOS (%) . | Annual costs in millions in 2020 USD (% of total costs in category) . |
|---|---|---|
| Pregnancy-related morbidities | ||
| GDM | 16.7 % | 61 (16) |
| gHTN | 14.3 % | 187 (50) |
| Preeclampsia | 8.1 % | 127 (34) |
| Total cost of pregnancy-related morbidities | 375 (100.0) | |
| Long-term morbidities | ||
| Type 2 diabetes mellitus | 3.93%* | 1500 (38) |
| MI | ___ | ___ |
| Stroke | 4.3%* | 2400 (62) |
| Total cost of long-term morbidities | 3900 (100.0) | |
| Total economic burden due to pregnancy-related or long-term morbidities | 4275 |
| Morbidity . | Excess prevalence of morbidity in PCOS (%) . | Annual costs in millions in 2020 USD (% of total costs in category) . |
|---|---|---|
| Pregnancy-related morbidities | ||
| GDM | 16.7 % | 61 (16) |
| gHTN | 14.3 % | 187 (50) |
| Preeclampsia | 8.1 % | 127 (34) |
| Total cost of pregnancy-related morbidities | 375 (100.0) | |
| Long-term morbidities | ||
| Type 2 diabetes mellitus | 3.93%* | 1500 (38) |
| MI | ___ | ___ |
| Stroke | 4.3%* | 2400 (62) |
| Total cost of long-term morbidities | 3900 (100.0) | |
| Total economic burden due to pregnancy-related or long-term morbidities | 4275 |
Abbreviations: GDM, gestational diabetes mellitus; gHTN, gestational hypertension; MI, myocardial infarction; PCOS, polycystic ovary syndrome; USD, US dollars.
*Weighted average prevalence of T2DM and stroke across age groups.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
